ROSIGLITAZONE AND PIOGLITAZONE PROTECT FROM INSULIN RESISTANCE-INDUCED HYPERTENSION INDEPENDENT OF THEIR INSULIN SENSITIZING ACTIVITY

Effect of Weight Reduction on Inflammatory Mediators in Patients with and without Metabolic Syndrome

POSSIBLE AMELIORATIVE ROLE OF SOME COMPOUNDS ON THE SIDE EFFECTS OF ROSIGLITAZONE

TNF ‐ Α And Glycemic Control in T2D: A Single Center Study

IMPACT OF GRANZYME B GENE EXPRESSION ON INFLAMMATION AND INSULIN RESISTANCE IN ATHEROSCLEROSIS

METABOLIC SYNDROME INPATIENTS WITH RHEUMATOID ARTHRITIS

A STUDY OF THE POTENTIAL PROTECTIVE THERAPEUTIC EFFECT OF THE ANTI OBESITY DRUG BRI 37344 IN AN EXPERIMENTAL MODEL OF INFLAMMATORY BOWEL DISEASE

Insulin resistance and Alzheimer’s disease: the role of defective insulin signaling and inflammation

HBA1C AND INSULIN RESISTANCE AS PREDICTORS FOR THE SEVERITY OF CORONARY ARTERY DISEASE AND SYSTOLIC HEART FAILURE IN NON DIABETIC PATIENTS.

Effect of Diclofenac on Plasma Glucose level, Insulin Resistance, Inflammatory Markers and Hepatocytes in Diabetic Albino Rats